The American Heart Association has announced the expansion of its Cardiovascular-Kidney-Metabolic Health Initiative to 15 regions across the United States, targeting the interconnected conditions that significantly increase the risk of heart disease and stroke. This initiative, supported by leading healthcare sponsors, aims to enroll 150 healthcare sites, potentially improving the care for over a quarter-million patients by enhancing awareness, screening, and treatment for cardiovascular-kidney-metabolic (CKM) syndrome.

CKM syndrome represents a critical public health challenge, combining the effects of heart disease, kidney disease, diabetes, and obesity. With only 10% of U.S. adults in excellent CKM health, the initiative’s focus on collaborative care models and community resources is a timely response to a growing crisis. The selected regions, including Atlanta, Baton Rouge, San Diego, and newly added areas like Bronx and Brooklyn, were chosen based on disease prevalence and community needs.

Chiadi Ndumele, M.D., Ph.D., M.H.S., FAHA, chair of the initiative’s advisory group, emphasizes the opportunity to improve CKM health through integrated care approaches. The initiative not only seeks to apply the latest therapies but also to establish a model of care that addresses the holistic needs of patients, recognizing the interconnected nature of their conditions.

For more information on CKM health and to access resources, visit heart.org/myCKMhealth. Healthcare organizations interested in joining the initiative can download the CKM Health Implementation Guide for free.

This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is 15 U.S. Regions Selected for Initiative to Combat Cardiovascular-Kidney-Metabolic Syndrome.